C-Reactive Protein

• 

  Subject Areas on Research

  • A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. 
  • A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. 
  • A blood-based biomarker panel to risk-stratify mild traumatic brain injury. 
  • A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. 
  • A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. 
  • A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. 
  • A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery. 
  • A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. 
  • AMPA receptor-dependent clustering of synaptic NMDA receptors is mediated by Stargazin and NR2A/B in spinal neurons and hippocampal interneurons. 
  • Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy. 
  • Abnormal bone turnover in cystic fibrosis adults. 
  • Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. 
  • Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy. 
  • Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. 
  • Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. 
  • Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. 
  • An investigation of vago-regulatory and health-behavior accounts for increased inflammation in posttraumatic stress disorder. 
  • An update on predictive biomarkers for major adverse cardiovascular events in patients undergoing vascular surgery. 
  • Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. 
  • Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study. 
  • Antibiotics and coronary heart disease. 
  • Antibiotics for acute bronchitis. 
  • Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. 
  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. 
  • Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. 
  • Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model. 
  • Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore? 
  • Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. 
  • Assessing the incremental predictive performance of novel biomarkers over standard predictors. 
  • Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). 
  • Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment. 
  • Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography. 
  • Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. 
  • Association between Bout Duration of Physical Activity and Health: Systematic Review. 
  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. 
  • Association between C-reactive protein and cognitive deficits in elderly men and women: a meta-analysis. 
  • Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis. 
  • Association of C-reactive protein and metabolic syndrome in a rural Chinese population. 
  • Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. 
  • Association of exome sequences with plasma C-reactive protein levels in >9000 participants. 
  • Association of parental hypertension with concentrations of select biomarkers in nonhypertensive offspring. 
  • Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study. 
  • Associations of candidate genes to age-related macular degeneration among racial/ethnic groups in the multi-ethnic study of atherosclerosis. 
  • Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. 
  • Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. 
  • Atherosclerosis and restenosis: an inflammatory issue. 
  • Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. 
  • B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. 
  • Bereavement is associated with reduced systemic inflammation: C-reactive protein before and after widowhood. 
  • Biological embedding of stress through inflammation processes in childhood. 
  • Biomarker-based risk prediction in the community. 
  • Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. 
  • Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study. 
  • Biomarkers in atrial fibrillation: a clinical review. 
  • Biomarkers in cardiovascular clinical trials: past, present, future. 
  • Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms? 
  • Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. 
  • Blood Substrate Collection and Handling Procedures under Pseudo-Field Conditions: Evaluation of Suitability for Inflammatory Biomarker Measurement. 
  • Body mass and cognitive decline are indirectly associated via inflammation among aging adults. 
  • C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. 
  • C-reactive protein and age-related macular degeneration and cataract: the singapore malay eye study. 
  • C-reactive protein and microalbuminuria in a multi-ethnic Asian population. 
  • C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. 
  • C-reactive protein and retinal microvascular caliber in a multiethnic asian population. 
  • C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. 
  • C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. 
  • C-reactive protein as a marker of melanoma progression. 
  • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. 
  • C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. 
  • C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. 
  • C-reactive protein, body mass index, and diabetic retinopathy. 
  • C-reactive protein, fibrinogen, and cardiovascular disease prediction. 
  • C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. 
  • C-reactive protein: a novel marker of cardiovascular risk. 
  • Cardiac markers in acute coronary syndromes-refining our knowledge. 
  • Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. 
  • Cardiorespiratory biomarker responses in healthy young adults to drastic air quality changes surrounding the 2008 Beijing Olympics. 
  • Cardiovascular risk factors, inflammation, and corneal arcus: the singapore malay eye study. 
  • Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. 
  • Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlife. 
  • Childhood bullying involvement predicts low-grade systemic inflammation into adulthood. 
  • Childhood maltreatment predicts adult inflammation in a life-course study. 
  • Childhood victimization and inflammation in young adulthood: A genetically sensitive cohort study. 
  • Children with both asthma and depression are at risk for heightened inflammation. 
  • Cholesterol emboli after invasive cardiac procedures. 
  • Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study. 
  • Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. 
  • Circulating galectin-3 in infections and non-infectious inflammatory diseases. 
  • Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. 
  • Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. 
  • Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. 
  • Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome. 
  • Clinical implications of systemic inflammatory response syndrome following thoracic aortic stent-graft placement. 
  • Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. 
  • Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. 
  • Coagulation abnormalities in patients with hip osteonecrosis. 
  • Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. 
  • Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. 
  • Complement factor H variant increases the risk of age-related macular degeneration. 
  • Correlates of serum lutein + zeaxanthin: findings from the Third National Health and Nutrition Examination Survey. 
  • Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. 
  • Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. 
  • Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood. 
  • Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. 
  • Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. 
  • Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. 
  • Declines in inflammation predict greater white matter microstructure in older adults. 
  • Deficiency of α-1-antitrypsin influences systemic iron homeostasis. 
  • Depression inhibits the anti-inflammatory effects of leisure time physical activity and light to moderate alcohol consumption. 
  • Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation: What the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control. 
  • Detection of iron deficiency in children with Down syndrome. 
  • Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis. 
  • Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. 
  • Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. 
  • Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men. 
  • Differing mechanisms for glutamate receptor aggregation on dendritic spines and shafts in cultured hippocampal neurons. 
  • Discordant risk: overweight and cardiometabolic risk in Chinese adults. 
  • Discriminative capacity of biomarkers for acute stroke in the emergency department. 
  • Discriminative value of inflammatory biomarkers for suspected sepsis. 
  • Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. 
  • Does this child have appendicitis? 
  • Duration of Antimicrobial Therapy for Intra-Abdominal Infection after Source Control: Role of C-Reactive Protein. 
  • Duration of empirical antibiotic therapy for infants suspected of early-onset sepsis. 
  • Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial. 
  • Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. 
  • Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. 
  • Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. 
  • Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterization. 
  • Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). 
  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. 
  • Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. 
  • Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. 
  • Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus. 
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment. 
  • Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. 
  • Emerging risk factors as markers for carotid intima media thickness scores. 
  • Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. 
  • Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial. 
  • Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. 
  • Excess factor VIII and hypercoagulability. 
  • Fibroblast growth factor 23 and Inflammation in CKD. 
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. 
  • First-trimester C-reactive protein and subsequent gestational diabetes. 
  • Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. 
  • Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. 
  • Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations. 
  • Genetic polymorphisms and the risk of stroke after cardiac surgery. 
  • Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. 
  • Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. 
  • Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. 
  • Glycated hemoglobin measurement and prediction of cardiovascular disease. 
  • Heterogeneity of healthy aging: comparing long-lived families across five healthy aging phenotypes of blood pressure, memory, pulmonary function, grip strength, and metabolism. 
  • High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. 
  • High neuroticism and low conscientiousness are associated with interleukin-6. 
  • High sensitivity C-reactive protein associated with different health predictors in middle-aged and oldest old Chinese. 
  • High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. 
  • High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States. 
  • High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. 
  • Hyaluronan interactions with innate immunity in lung biology. 
  • Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. 
  • Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. 
  • In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane. 
  • Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis. 
  • Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment? 
  • Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity. 
  • Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. 
  • Inflammation and hypertension: new clinical information on pentraxin-3. 
  • Inflammation in coronary artery disease. 
  • Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. 
  • Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. 
  • Inflammatory biomarkers in heart failure. 
  • Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists. 
  • Inflammatory markers and heart rate variability in women with coronary heart disease. 
  • Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. 
  • Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline? 
  • Insulin resistance but not inflammation is associated with gestational hypertension. 
  • Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. 
  • Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. 
  • Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. 
  • Is chronic asthma associated with shorter leukocyte telomere length at midlife? 
  • Is there a role for albumin and C-reactive protein levels for prognostication in acute heart failure? 
  • Islands of Inflammation: Neurosarcoidosis. 
  • Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. 
  • Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. 
  • Left atrial enlargement: a cause of stroke? 
  • Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitis. 
  • Liposarcoma presenting as an intraluminal ureteral mass. 
  • Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. 
  • Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial. 
  • Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. 
  • Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. 
  • Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. 
  • Markers of cardiac ischemia, injury, and inflammation. 
  • Meat, eggs, full-fat dairy, and nutritional boogeymen: Does the way in which animals are raised affect health differently in humans? 
  • Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. 
  • Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. 
  • Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. 
  • Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. 
  • Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. 
  • N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. 
  • Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. 
  • Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. 
  • Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level. 
  • Night shift work and cardiovascular disease biomarkers in female nurses. 
  • Nocturnal heart rate and inflammation. 
  • Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. 
  • Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. 
  • Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. 
  • Obesity and preeclampsia: the potential role of inflammation. 
  • Peeing pentraxins. 
  • Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. 
  • Personality and inflammation: the protective effect of openness to experience. 
  • Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. 
  • Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis. 
  • Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. 
  • Plasminogen activator inhibitor-1 (PAI-1) activity and retinal vascular calibre in type 2 diabetes. 
  • Platelet reactivity and thrombogenicity in postmenopausal women. 
  • Pleiotropy among common genetic loci identified for cardiometabolic disorders and C-reactive protein. 
  • Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. 
  • Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. 
  • Population Distributions of Thymic Function in Adults: Variation by Sociodemographic Characteristics and Health Status. 
  • Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines. 
  • Predicting gestational diabetes: choosing the optimal early serum marker. 
  • Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. 
  • Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. 
  • Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. 
  • Predisposition to arrhythmias: electrolytes, uremic fibrosis, other factors. 
  • Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. 
  • Prevalence and characteristics of choroidal nevi: the multi-ethnic study of atherosclerosis. 
  • Prevalence and risk factors for retinopathy in persons without diabetes: the Singapore Indian Eye Study. 
  • Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. 
  • Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction. 
  • Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: evaluation of periprosthetic shoulder infection. 
  • Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. 
  • Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial. 
  • Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. 
  • Proinflammatory state, hepcidin, and anemia in older persons. 
  • Race differences in the relation of vitamins A, C, E, and β-carotene to metabolic and inflammatory biomarkers. 
  • Racial Differences in Elevated C-Reactive Protein Among US Older Adults. 
  • Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. 
  • Redefining medical treatment in the management of unstable angina. 
  • Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis. 
  • Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention. 
  • Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. 
  • Response of high-sensitivity C-reactive protein to exercise training in an at-risk population. 
  • Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT". 
  • Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome". 
  • Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. 
  • Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. 
  • Retinal venular calibre is increased in patients with autoimmune rheumatic disease: a case-control study. 
  • Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study. 
  • Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients. 
  • Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. 
  • Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. 
  • Sensitivity of C-reactive protein for the identification of patients with laboratory-confirmed bacterial infections in northern Tanzania. 
  • Serum C-reactive protein level and prediabetes in two Asian populations. 
  • Serum C-reactive protein level and prehypertension in two Asian populations. 
  • Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats. 
  • Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. 
  • Serum cystatin C and prediabetes in non-obese US adults. 
  • Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. 
  • Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation. 
  • Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. 
  • Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event? 
  • Socioeconomic indices as independent correlates of C-reactive protein in the National Longitudinal Study of Adolescent Health. 
  • Surrogate markers for late cardiac allograft survival. 
  • Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. 
  • Synaptically targeted narp plays an essential role in the aggregation of AMPA receptors at excitatory synapses in cultured spinal neurons. 
  • Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. 
  • Systemic involvement in ACS: Using CMR imaging to compare the aortic wall in patients with and without acute coronary syndrome. 
  • Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome. 
  • Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein. 
  • The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. 
  • The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part I. 
  • The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II. 
  • The cortisol:C-reactive protein ratio and negative affect reactivity in depressed adults. 
  • The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients. 
  • The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. 
  • The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. 
  • The effects of written emotional disclosure and coping skills training in rheumatoid arthritis: a randomized clinical trial. 
  • The impact of cigarette smoking on 24-hour blood pressure, inflammatory and hemostatic activity, and cardiovascular risk in Japanese hypertensive patients. 
  • The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. 
  • The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. 
  • The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. 
  • Threat-related amygdala activity is associated with peripheral CRP concentrations in men but not women. 
  • Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. 
  • Unraveling the pathophysiology of acute heart failure: an inflammatory proposal. 
  • Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials). 
  • Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). 
  • Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes. 
  • Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore. 
  • Valvular disease. 
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. 
  • Vegetations in endocarditis: big is bad, but is there more to it? 
  • What to expect from net reclassification improvement with three categories. 
• 

  Keywords of People

  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology
  • Tsalik, Ephraim, Associate Professor of Medicine, Molecular Genetics and Microbiology